Biotechnology
Application of biological systems and organisms to develop products and technologies
Source: Grand View Research. Figures checked October 21, 2026.
Market Overview
Market Size
$1.55T (2023). Source: Grand View Research, Biotechnology Market Size, Share & Trends Analysis Report.
Projection
$3.88T (2030) (2024-2030).
Scope and other estimates
This figure covers all of biotechnology, including health and agriculture, which is broader than the segments below. Precedence Research puts the market at $1.77T in 2025.
Description
Synthetic biology, gene editing, biomanufacturing, precision medicine
Key Technology Segments
Synthetic Biology
Engineering biological systems for new functions
Gene Editing
CRISPR and other gene editing technologies
Biomanufacturing
Production of materials and chemicals using biological processes
Key Players and Research Institutions
Ginkgo Bioworks
enterpriseSynthetic biology platform for designing and engineering organisms.
Public (NYSE: DNA)
Visit website →CRISPR Therapeutics
enterpriseGene-editing therapeutics company developing CRISPR/Cas9-based medicines.
Public (Nasdaq: CRSP)
Visit website →Novonesis
enterpriseBiosolutions company formed in 2024 from the merger of Novozymes and Chr. Hansen.
Public (Nasdaq Copenhagen: NSIS B)
Visit website →MIT
universityResearch institution with leading synthetic biology and gene editing programs.
Commercialization Pathways
Licensing
high feasibilityBiotech innovations often licensed to pharma companies for development and commercialization.
Spinout
high feasibilityStrong biotech startup ecosystem with significant investor interest and clear regulatory pathways.
Partnership
high feasibilityStrategic partnerships with pharma and biotech companies are common for early-stage technologies.
Regulatory Considerations
- •FDA approval processes
- •Clinical trial requirements
- •Biosafety regulations
- •Intellectual property protection
Frequently Asked Questions
What is the market size for biotechnology?
Grand View Research estimates market size at $1.55T (2023), reaching $3.88T (2030) (13.96% CAGR). This figure covers all of biotechnology, including health and agriculture, which is broader than the segments below. Precedence Research puts the market at $1.77T in 2025.
What are the main commercialization pathways for biotechnology?
The primary commercialization pathways include licensing, spinout, partnership. Spinouts are particularly viable given strong investor interest.
Which universities are leading in biotechnology research?
Leading universities in biotechnology include MIT, Stanford, UC Berkeley, and others. These institutions have strong research programs and commercialization track records in this area.
What are the key technology segments in biotechnology?
Key technology segments include Synthetic Biology, Gene Editing, Biomanufacturing. These segments represent different areas of innovation and market opportunity within the broader biotechnology category.
Leading Universities
MIT
$1.1B R&D (FY2024) • 38 startups (FY2025)
Stanford
$1.6B R&D (FY2024) • 28 startups (FY2025)
UC Berkeley
$1.1B R&D (FY2024) • 9 startups (FY2024)
Harvard
$1.5B R&D (FY2024) • 20 startups (FY2025)
Johns Hopkins
$4.1B R&D (FY2024) • 17 startups (FY2026)
Related Tools
Get Market Intelligence
Use Commercify to analyze market opportunities and build your commercialization strategy.
See plans & pricing